A clinical trial to study the effects of a drug - tranexamic acid given through vapour form or injection form to patients coming to emergencycoughing out blood.
Phase 4
- Conditions
- Health Condition 1: J470- Bronchiectasis with acute lower respiratory infection
- Registration Number
- CTRI/2019/05/019337
- Lead Sponsor
- AIIMS New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult( >18years) patients presenting to the Emergency Department with active hemoptysis.
Exclusion Criteria
1) Patients already received tranexamic acid before presenting to the
hospital.
2) Intubated patients on mechanical ventilation.
3) Patients with massive life-threatening hemoptysis who need to be
immediately shifted for interventional procedures.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cessation of bleeding in patients presenting to ED with active <br/ ><br>hemoptysis at 30 minutes after initiation of treatment.Timepoint: 30 minutes after initiation of treatment.
- Secondary Outcome Measures
Name Time Method 1. Need for urgent <br/ ><br>interventional procedures â?? Bronchoscopy and <br/ ><br>bronchial artery embolization(BAE).Timepoint: Time of interventional procedure;2. Reduction in volume of hemoptysis at 6, 12 and 24 hours after <br/ ><br>presenting to Emergency department(ED).Timepoint: 6,12 and 24 hours